Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhaoqing Fangcheng Pharmaceutical is a specialized pharmaceutical manufacturer based in Zhaoqing, China, focusing on steroid hormone drugs and active pharmaceutical ingredients (APIs). As a subsidiary of Zhejiang Xianju Pharmaceutical, the company leverages advanced chemical synthesis capabilities to produce a wide range of essential medicines, including spironolactone and various corticosteroids. The company maintains modern, GMP-certified production facilities that supply both the Chinese domestic market and international clients. Its core business encompasses the entire value chain from API production to finished dosage forms like tablets and injections. Zhaoqing Fangcheng is recognized as a key player in the regional life sciences sector, contributing significantly to the production of endocrine and cardiovascular therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhaoqing Fangcheng Pharmaceutical.